Sfoglia per Autore
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients
2024 Villa, M; Malighetti, F; Sala, E; Sharma, G; Arosio, G; Gemelli, M; Manfroni, C; Fontana, D; Cordani, N; Meneveri, R; Zambon, A; Piazza, R; Pagni, F; Cortinovis, D; Mologni, L
A cross-sectional analysis of treatment patterns in small-cell lung cancer in five European countries
2024 Reguart, N; Pérol, M; Cortinovis, D; Puntis, S; Öhrling, K; Archangelidi, O; Louie, K; Blackhall, F; Sebastian, M
Economic assessment of NGS testing workflow for NSCLC in a healthcare setting
2024 Seminati, D; L'Imperio, V; Casati, G; Ceku, J; Pilla, D; Scalia, C; Gragnano, G; Pepe, F; Pisapia, P; Sala, L; Cortinovis, D; Bono, F; Malapelle, U; Troncone, G; Novello, S; Pagni, F
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma
2024 Szlosarek, P; Creelan, B; Sarkodie, T; Nolan, L; Taylor, P; Olevsky, O; Grosso, F; Cortinovis, D; Chitnis, M; Roy, A; Gilligan, D; Kindler, H; Papadatos-Pastos, D; Ceresoli, G; Mansfield, A; Tsao, A; O’Byrne, K; Nowak, A; Steele, J; Sheaff, M; Shiu, C; Kuo, C; Johnston, A; Bomalaski, J; Zauderer, M; Fennell, D; Rybkin, I; Rolfo, C; Mackean, M; Steele, N; Franks, K; Shaw, P; Lind, M; Upadhyay, S; John, T; Karapetis, C; Srivastav, R; Mencoboni, M; Chella, A; Zilembo, N; de Marinis, F; Stella, M; Chong, I; Wang, C; Null, N
The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database
2024 Malapelle, U; Passiglia, F; Pepe, F; Pisapia, P; Lucia Reale, M; Cortinovis, D; Fraggetta, F; Galetta, D; Garbo, E; Graziano, P; Pagni, F; Pasello, G; Piovano, P; Pilotto, S; Tiseo, M; Genova, C; Righi, L; Troncone, G; Novello, S
Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program
2024 Passiglia, F; Lucia Reale, M; Lo Russo, G; Pasello, G; Minuti, G; Bulotta, A; Galetta, D; Pelizzari, G; Sini, C; Bria, E; Roca, E; Pilotto, S; Genova, C; Metro, G; Citarella, F; Chiari, R; Cortinovis, D; Delmonte, A; Russo, A; Tiseo, M; Cerea, G; Carta, A; Scotti, V; Vavalà, T; Brambilla, M; Buffoni, L; Buosi, R; Catania, C; Gori, S; Grisanti, S; Agustoni, F; Garbo, E; Malapelle, U; Novello, S
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed
2024 Leonetti, A; Perrone, F; Puntoni, M; Maglietta, G; Bordi, P; Bria, E; Vita, E; Gelsomino, F; De Giglio, A; Gelibter, A; Siringo, M; Mazzoni, F; Caliman, E; Genova, C; Bertolini, F; Guaitoli, G; Passiglia, F; Delcuratolo, M; Montrone, M; Cerea, G; Pasello, G; Roca, E; Belluomini, L; Cecere, F; Guida, A; Manzo, A; Adamo, V; Rastelli, F; Bulotta, A; Citarella, F; Toschi, L; Zoratto, F; Cortinovis, D; Berardi, R; Follador, A; Carta, A; Camerini, A; Salerno, F; Silva, R; Baldini, E; Cortellini, A; Brighenti, M; Santoni, M; Malorgio, F; Caminiti, C; Tiseo, M
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study
2023 Lee, S; Schulz, C; Prabhash, K; Kowalski, D; Szczesna, A; Han, B; Rittmeyer, A; Talbot, T; Vicente, D; Califano, R; Cortinovis, D; Le, A; Huang, D; Liu, G; Cappuzzo, F; Contreras, J; Reck, M; Palmero, R; Mak, M; Hu, Y; Morris, S; Höglander, E; Connors, M; Biggane, A; Vollan, H; Peters, S
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer
2023 Heather, W; Moishe, L; Terufumi, K; Masahiro, T; Se-Hoon, L; Shugeng, G; Ke-Neng, C; Christophe, D; Margarita, M; Ekkehard, E; Gastón L, M; Olivier, B; Delvys, R; Jamie E, C; Silvia, N; Jing, Y; Steven M, K; Ayman, S; Spicer, ; D Marcelo Tatangelo, J; Flores, M; Pastor, A; Puig, J; Martinengo, G; Varela, M; Brocca, C; Wong, M; Hui, R; Dooms, C; Vansteenkiste, J; Demedts, I; Sibille, A; Surmont, V; Deschepper, K; Lambrechts, M; Dias, J; Rafael Martins De Marchi, P; Alves, G; Henrique Araujo, L; Matias, D; Chaves, F; Franke, F; Teixeira, C; Tabacof, J; Faria, L; Morbeck, I; Henrique Cronemberger, E; Lima, I; Sardenberg, R; de Paiva Junior, T; Dutra, C; Luiz Guimaraes, J; Begin, P; Langleben, A; Liu, G; Liberman, M; Spicer, J; Gao, S; Zhao, G; Jiang, T; Yan, X; Hu, J; Chen, J; Tan, L; Wang, Q; Li, S; Chen, K; Yang, Y; Bai, J; Ma, S; Chen, H; Chen, Q; Wang, W; Zhang, L; Zhu, Y; Vanakesa, T; Zasadny, X; Duchemann, B; Girard, N; Bylicki, O; Berard, H; Thiberville, L; Mennecier, B; Mazieres, J; Eigendorff, E; Bonnet, R; Fix, P; Reck, M; Rittmeyer, A; Reinacher-Schick, A; Wehler, T; Lehmann, M; Serke, M; Wesseler, C; Täuscher, D; Lang, S; Wermke, M; Grohe, C; Wirtz, H; Kollmeier, J; Ritgen, M; Mueller, A; Frohling, K; Vogel, G; Faehling, M; Cuffe, S; Collins, D; Delmonte, A; Gilli, M; Piantedosi, F; Ogliari, F; Bulotta, A; Gregorc, V; Gianni, L; Grisanti, S; Intagliata, S; Roca, E; Ferrari, V; Berruti, A; Cortinovis, D; Lo Russo, G; Ferrara, R; Garassino, M; Rita Migliorino, M; Novello, S; Santoro, A; Signorelli, D; Tsuboi, M; Okada, M; Kato, T; Nishio, W; Kuroda, H; Shimizu, J; Sakao, Y; Sugio, K; Horinouchi, H; Takamochi, K; Saji, H; Tanaka, F; Ikeda, N; Muto, S; Shio, Y; Suzuki, H; Hegmane, A; Cicenas, S; Zemaitis, M; Kek Pang, Y; Yew Heng, F; Leong Yu, K; Lowczak, A; Makles, K; Bryl, M; Zurawski, B; Pawlak, I; Han, J; Lee, S; Kim, J; Yong Shim, B; Cebotaru, C; Ganea, D; Scheusan, R; Ciurescu, I; Mazilu, L; Ungureanu, A; Gal, C; Ciubotaru, E; Iordan, I; Berceanu-Ion, R; Ciuleanu, T; Laktionov, K; Karaseva, N; Smagina, M; Luft, A; Afanasyev, S; Nesterova, A; Levchenko, E; Arkhipov, A; Fedenko, A; Ruff, P; Jacobs, C; Fourie, S; Carcereny, E; Calles Blanco, A; Rodriguez Abreu, D; Majem Tarruella, M; Bosch Barrera, J; Bernabe Caro, R; Nadal Alforja, E; Martnez Marti, A; Liao, B; Huang, H; Chiu, C; Wang, C; Tsai, C; Voitko, N; Kryzhanivska, A; Kolesnik, O; Levenko, O; Kolesnik, O; Bondarenko, I; Trukhin, D; Ursol, G; Paramonov, V; Sokur, I; Khan, S; Arora, A; Goranov, B; Greystoke, A; Ahmed, S; Pope, T; O'Brien, M; Charu, V; Cobb, P; Costin, D; Weksler, B; Schumacher, L; Finley, G; Furqan, M; Gentzler, R; Misleh, J; Guarino, M; Halmos, B; Keresztes, R; Jain, K; Yan Lou, Y; Molina, J; Liu-Dumlao, T; Zhao, Q; Niu, J; Taysir Hammoud, Z; Rybkin, I; Cuevo, R; Fernando, H; Schiller, J; Srkalovic, G; Koontz, M; Stampleman, L; Anderson, I; Villaruz, L; Wang, S; Komiya, T; Jain, S; Starodub, A; Wakelee, H; Kishor Ganti, A; Ernani, V; Kristedja, T; O'Day, S; Radhi, S; Sangal, A; Duvivier, H; Rich, P; Kazmi, S; Pollock, T; Chaft, J; Rathnasabapathy, C; Savvides, P; Costas, K; Kaywin, P; Villalona-Calero, M; Alekshun, T; Chen, K; Rao, S; Siegel, R
An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective
2023 Cordani, N; Bianchi, T; Ammoni, L; Cortinovis, D; Cazzaniga, M; Lissoni, A; Landoni, F; Canova, S
Sharing Experience with Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors in Lung Cancer: An Italian Expert Panel Discussion
2023 Gridelli, C; Tiseo, M; Cortinovis, D; Migliorino, M; Barbieri, V; Bironzo, P; Bearz, A; Attili, I; de Marinis, F
Novel Therapeutic Options for Small Cell Lung Cancer
2023 Canova, S; Trevisan, B; Abbate, M; Colonese, F; Sala, L; Baggi, A; Bianchi, S; D'Agostino, A; Cortinovis, D
Project R. Evolution for improving clinical research in Italy: challenges and strategies
2022 Arizio, F; Bonardi, A; Cortinovis, D; Costanzo, A; Cristinziano, A; Delle Monache, L; Landolfi, R; Lettino, M; Luppi, F; Petrangolini, T; Tassielli, D
Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients
2022 Malapelle, U; Pilotto, S; Reale, M; Passiglia, F; Pisapia, P; Pepe, F; Belluomini, L; Galetta, D; Cortinovis, D; Tiseo, M; Passaro, A; Seminati, D; Pagni, F; Parra, H; Migliorino, M; Rocco, D; Troncone, G; Novello, S
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT
2022 Monaco, L; De Bernardi, E; Bono, F; Cortinovis, D; Crivellaro, C; Elisei, F; L'Imperio, V; Landoni, C; Mathoux, G; Musarra, M; Pagni, F; Turolla, E; Messa, C; Guerra, L
Vanishing bile duct syndrome following pembrolizumab infusion: case report and review of the literature
2022 Gemelli, M; Carbone, M; Abbate, M; Mancin, M; Zucchini, N; Colonese, F; Invernizzi, P; Bidoli, P; Cortinovis, D
Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial
2022 Garassino, M; Mazieres, J; Reck, M; Chouaid, C; Bischoff, H; Reinmuth, N; Cove-Smith, L; Mansy, T; Cortinovis, D; Migliorino, M; Delmonte, A; Sánchez, J; Chara Velarde, L; Bernabe, R; Paz-Ares, L; Perez, I; Trunova, N; Foroutanpour, K; Faivre-Finn, C
Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study
2022 Celio, L; Cortinovis, D; Cogoni, A; Cavanna, L; Martelli, O; Carnio, S; Collovà, E; Bertolini, F; Petrelli, F; Cassano, A; Chiari, R; Zanelli, F; Pisconti, S; Vittimberga, I; Letizia, A; Misino, A; Gernone, A; Bonizzoni, E; Pilotto, S; De Placido, S; Bria, E
First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers
2022 Felip, E; Moreno, V; Morgensztern, D; Curigliano, G; Rutkowski, P; Trigo, J; Calvo, A; Kowalski, D; Cortinovis, D; Plummer, R; Maio, M; Ascierto, P; Vladimirov, V; Cervantes, A; Zudaire, E; Hazra, A; T'Jollyn, H; Bandyopadhyay, N; Greger, J; Attiyeh, E; Xie, H; Calvo, E
Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancer
2022 Heitzer, E; van den Broek, D; Denis, M; Hofman, P; Hubank, M; Mouliere, F; Paz-Ares, L; Schuuring, E; Sültmann, H; Vainer, G; Verstraaten, E; de Visser, L; Cortinovis, D
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile